Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
EVAX

Overview Financials Analysis Smart Money

Evaxion Biotech A/S

EVAX · NASDAQ

Analyze with AI

Filings1

Total reported value$219.8K

Manager	Shares	Value	Change
Telemetry Investments, L.L.C.	37.5K	$219.8K	+18.5%

SymbolEVAX

Market Cap$37.0M

IPO Date2021-02-05

CEOHelen Tayton-Martin

Employees46

SectorHealthcare

IndustryBiotechnology

CountryDK

ExchangeNASDAQ Capital Market

Mega Fortune Company Limited

MGRT

$13.05

+143.93%

Processa Pharmaceuticals, Inc.

PCSA

$6.68

+122.30%

cbdMD, Inc.

YCBD

$2.27

+58.74%

Agape ATP Corporation

ATPC

$0.1408

+56.44%

IMAC Holdings, Inc.

BACK

$0.153

+50.00%

Peers

Reviva Pharmaceuticals Holdings, Inc.

RVPH · NASDAQ

$0.6161

-3.39%

Mural Oncology plc

MURA · NASDAQ

$2.04

+0.00%

Annovis Bio, Inc.

ANVS · NYSE

$3.62

-7.77%

PolyPid Ltd.

PYPD · NASDAQ

$3.93

-0.51%

Generation Bio Co.

GBIO · NASDAQ

$5.36

-0.37%

BioAtla, Inc.

BCAB · NASDAQ

$0.7825

+2.95%

Veru Inc.

VERU · NASDAQ

$2.23

-8.61%

SAB Biotherapeutics, Inc.

SABS · NASDAQ

$3.96

-0.75%

Celularity Inc.

CELU · NASDAQ

$1.30

-3.70%

BioXcel Therapeutics, Inc.

BTAI · NASDAQ

$1.80

-4.26%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.